Buprenorphine group medical visits for drug users at risk for HIV

丁丙诺啡对有艾滋病毒风险的吸毒者进行团体医疗就诊

基本信息

  • 批准号:
    8922622
  • 负责人:
  • 金额:
    $ 6.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-04-15 至 2015-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Group medical visits to intensify buprenorphine treatment in primary care Opioid addiction and opioid overdose deaths have increased rapidly in the United States. Access to opioid addiction treatment has improved through successful implementation of buprenorphine maintenance treatment (BMT) in primary care; however, treatment outcomes, including abstinence from opioids, have yet to be optimized. Our overarching goal is to reduce the consequences of opioid addiction, including HIV transmission, by improving BMT outcomes in primary care. The objective of this study is to develop a manualized theory-guided behavioral intervention based on the model of group medical visits, which will be used in primary care to intensify BMT for patients with ongoing opioid abuse. This proposal aims to: 1.) determine key components of a group-based BMT intervention (G-BMT) that will enhance buprenorphine treatment outcomes within primary care; 2.) develop the G-BMT intervention; and 3.) preliminarily test G-BMT for efficacy, acceptability, and feasibility in primary care. These aims will be achieved by conducting focus groups with eight BMT providers and 40 BMT patients using Social Cognitive Theory as a theoretical framework to determine potential components for the G-BMT intervention that will be acceptable to patients and likely to result in reduced opioid abuse. Based on this formative research, an intervention guide for G-BMT will be developed to provide a novel option for treatment intensification in primary care. In a randomized trial, we will preliminarily test G-BMT (8 sessions over 16 weeks) for feasibility, acceptability, and efficacy, by comparing G-BMT to treatment as usual (TAU) for BMT patients with ongoing opioid abuse while receiving standard office-based BMT. We hypothesize that participants randomized to G- BMT will have higher abstinence rates (primary outcome, efficacy), fewer HIV risk behaviors (efficacy), greater satisfaction with treatment (acceptability) and higher visit adherence (feasibility) than participants randomized to TAU. Following this study, we will use feasibility and acceptability data to further modify the G-BMT intervention, and in a multi-site randomized trial, we will fully examine its effectiveness at improving abstinence, reducing HIV-risk behaviors, and increasing retention in treatment for BMT patients with ongoing opioid abuse.
 描述(由申请人提供):在美国,加强初级保健中丁丙诺啡治疗的团体医疗访问阿片类药物成瘾和阿片类药物过量死亡人数迅速增加。通过在初级保健中成功实施丁丙诺啡维持治疗,获得阿片类成瘾治疗的机会有所改善;然而,治疗结果,包括戒断阿片类药物,尚未得到优化。我们的总体目标是通过改善初级保健中的BMT结果来减少阿片类药物成瘾的后果,包括艾滋病毒传播。本研究的目的是开发一种基于小组医疗访问模型的手动理论指导的行为干预,该干预将用于初级保健,以加强持续阿片类药物滥用患者的BMT。本建议旨在:1.)确定基于组的BMT干预(G-BMT)的关键组成部分,该干预将增强初级保健中的丁丙诺啡治疗结果; 2.)开发G-BMT干预措施; 3.)初步测试G-BMT在初级保健中的有效性、可接受性和可行性。这些目标将通过与8名BMT提供者和40名BMT患者进行焦点小组来实现,使用社会认知理论作为理论框架,以确定患者可接受并可能导致减少阿片类药物滥用的G-BMT干预的潜在组成部分。基于这一形成性研究,将制定G-BMT的干预指南,为初级保健中的强化治疗提供一种新的选择。在一项随机试验中,我们将初步测试G-BMT(16周内8次)的可行性、可接受性和疗效,方法是将G-BMT与常规治疗(TAU)进行比较,以治疗持续滥用阿片类药物的BMT患者,同时接受标准的基于办公室的BMT。我们假设随机分配到G-BMT组的受试者与随机分配到TAU组的受试者相比,禁欲率(主要结局,疗效)更高,HIV风险行为(疗效)更少,对治疗的满意度(可接受性)更高,访视依从性(可行性)更高。在这项研究之后,我们将使用可行性和可接受性数据来进一步修改G-BMT干预, 在一项多中心随机试验中,我们将全面检查其在改善戒断、减少HIV风险行为和增加持续阿片类药物滥用的BMT患者治疗保留率方面的有效性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Aaron D Fox其他文献

Aaron D Fox的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Aaron D Fox', 18)}}的其他基金

Onsite PTSD Treatment to Improve MOUD Outcomes (OPTIMO): a hybrid Type 1 effectiveness-implementation trial of harm reduction PTSD care at syringe service programs
改善 MOUD 结果的现场 PTSD 治疗 (OPTIMO):注射器服务项目中减少伤害 PTSD 护理的 1 型混合有效性实施试验
  • 批准号:
    10812813
  • 财政年份:
    2023
  • 资助金额:
    $ 6.96万
  • 项目类别:
Mentorship in research on opioid use disorder, HIV and marginalized populations
指导阿片类药物使用障碍、艾滋病毒和边缘化人群的研究
  • 批准号:
    10619044
  • 财政年份:
    2023
  • 资助金额:
    $ 6.96万
  • 项目类别:
Buprenorphine treatment at syringe exchanges to reduce opioid misuse and HIV risk
注射器交换时丁丙诺啡治疗可减少阿片类药物滥用和艾滋病毒风险
  • 批准号:
    9411340
  • 财政年份:
    2017
  • 资助金额:
    $ 6.96万
  • 项目类别:
Buprenorphine treatment at syringe exchanges to reduce opioid misuse and HIV risk
注射器交换时丁丙诺啡治疗可减少阿片类药物滥用和艾滋病毒风险
  • 批准号:
    9697277
  • 财政年份:
    2017
  • 资助金额:
    $ 6.96万
  • 项目类别:
Buprenorphine treatment at syringe exchanges to reduce opioid misuse and HIV risk
注射器交换时丁丙诺啡治疗可减少阿片类药物滥用和艾滋病毒风险
  • 批准号:
    10364785
  • 财政年份:
    2017
  • 资助金额:
    $ 6.96万
  • 项目类别:
Buprenorphine treatment at syringe exchanges to reduce opioid misuse and HIV risk
注射器交换时丁丙诺啡治疗可减少阿片类药物滥用和艾滋病毒风险
  • 批准号:
    10363611
  • 财政年份:
    2017
  • 资助金额:
    $ 6.96万
  • 项目类别:
Impact of PTSD and trauma reexposure on buprenorphine maintenance treatment in syringe exchange programs
注射器交换项目中 PTSD 和创伤再暴露对丁丙诺啡维持治疗的影响
  • 批准号:
    10115954
  • 财政年份:
    2017
  • 资助金额:
    $ 6.96万
  • 项目类别:
Buprenorphine group medical visits for drug users at risk for HIV
丁丙诺啡对有艾滋病毒风险的吸毒者进行团体医疗就诊
  • 批准号:
    9050663
  • 财政年份:
    2015
  • 资助金额:
    $ 6.96万
  • 项目类别:
Buprenorphine group medical visits for drug users at risk for HIV
丁丙诺啡对有艾滋病毒风险的吸毒者进行团体医疗就诊
  • 批准号:
    9185507
  • 财政年份:
    2015
  • 资助金额:
    $ 6.96万
  • 项目类别:
Buprenorphine Facilitated Access and Supportive Treatment in Former Inmates
丁丙诺啡促进前囚犯获得和支持治疗
  • 批准号:
    8879087
  • 财政年份:
    2012
  • 资助金额:
    $ 6.96万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 6.96万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 6.96万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 6.96万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 6.96万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 6.96万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 6.96万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 6.96万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 6.96万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 6.96万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 6.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了